Oncotelic Therapeutics, Inc. (OTLC) › Total AssetsOncotelic Therapeutics, Inc. (OTLC) — Total AssetsAnnual figures by fiscal year, from SEC filings.2010: $5.57M2011: $11.06M2012: $5.45M2013: $7.29M2014: $30.42M2015: $27.45M2016: $14.11M2017: $1.17M2018: $2.75M2019: $23.68M2020: $23.66M2021: $23.61M2022: $36.12M2023: $30.01M2024: $26.68M2025: $393.09M$393.09M2010Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$393.09M+1373.5%2024$26.68M-11.1%2023$30.01M-16.9%2022$36.12M+53.0%2021$23.61M-0.2%2020$23.66M-0.1%2019$23.68M+762.0%2018$2.75M+134.5%2017$1.17M-91.7%2016$14.11M-48.6%2015$27.45M-9.8%2014$30.42M+317.1%2013$7.29M+33.9%2012$5.45M-50.7%2011$11.06M+98.6%2010$5.57M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share